{"id":"W4410815972","doi":"10.1200/jco.2025.43.16_suppl.tps4224","title":"Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and pancreatic neuroendocrine tumours.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Queen's University; Ottawa Hospital","funders":"Canadian Institutes of Health Research; Tour de Cure","keywords":"Radionuclide therapy; Peptide receptor; Somatostatin; Medicine; Somatostatin receptor; Internal medicine; Neuroendocrine tumors; Gastroenterology; Oncology; Receptor; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00360761,0.001347138,0.002330632,0.0004441902,0.0005834981,0.001100124,0.0006858449,0.0019969,0.008379471],"category_scores_gemma":[0.005937227,0.0004340554,0.002335926,0.0005464054,0.001023431,0.0009396824,0.0006000761,0.003245272,0.0008285405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001299897,"about_ca_system_score_gemma":0.002891387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002624834,"about_ca_topic_score_gemma":0.007407258,"domain_scores_codex":[0.9980502,0.001369814,0.0001116693,0.000196632,0.0001505871,0.0001209905],"domain_scores_gemma":[0.9972704,0.0008937162,0.0007341252,0.0001617836,0.0002720003,0.0006680052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9660661,0.004807292,0.001410243,0.001795054,0.002006027,0.00008252852,0.0001025751,0.0002675403,0.001071833,0.0003236822,0.002443026,0.01962402],"study_design_scores_gemma":[0.9538642,0.03958937,0.001928275,0.0001379527,0.0009761249,0.00007009528,0.00002854622,0.0002367431,0.0001180663,0.0002754454,0.002761579,0.00001374187],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9240001,0.02258951,0.001721061,0.006444042,0.002376047,0.02981427,0.004207121,0.0002540277,0.008593899],"genre_scores_gemma":[0.9325448,0.00735736,0.006121467,0.005305813,0.001168474,0.03645531,0.003204655,0.00006353825,0.007778517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008379471,"threshold_uncertainty_score":0.02803206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0907963499686057,"score_gpt":0.4666050026430885,"score_spread":0.3758086526744828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}